Prof. Ferdinando Nicoletti: co-founder of CRESENCE AS, Member of the Board, Acting CSO. Professor of General Pathology and Immunology, University of Catania (Italy) He serves in the Editorial Boards of several international journals including Antioxidants and Redox Signalling, Basic and Clinical Pharmacology and Toxicology and the European Journal of Pharmacology. Co-founder of GaNiAl Immunotherapeutic Inc. (USA), of Onconox (Copenhagen, Denmark) and AURA Biopharm (Oslo, Norway). Successful exit with each company; 20 years of collaboration with pharmas.